Foghorn Therapeutics Inc. (FHTX) Revenue 2020–2025
Foghorn Therapeutics Inc. (FHTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$30.9MFY2025 · since FY2020: $430,000 → $30.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $30.9M | +36.8% |
| FY2024 | $22.6M | -33.8% |
| FY2023 | $34.2M | +77.6% |
| FY2022 | $19.2M | +1357.8% |
| FY2021 | $1.3M | +206.7% |
| FY2020 | $430,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FHTX financial trends
FHTX Net incomeFHTX Net marginFHTX Gross profitFHTX Gross marginFHTX Operating incomeFHTX Operating marginFHTX Operating cash flowFHTX Free cash flowFHTX Capital expendituresFHTX Return on equityFHTX Stock buybacksFHTX Dividends paidFHTX Total assetsFHTX Total liabilitiesFHTX Shareholders’ equityFHTX overview →